Work

Phase I Study of R24 in Patients with Metastatic Melanoma Including Evaluation of Immunologic Parameters

Year: 1998

Type: article

Study design: Clinical Trial

Source: Cancer Biotherapy and Radiopharmaceuticals

DOI: 10.1089/cbr.1998.13.13

Authors: Henry C. Maguire, David Berd, Edmund C. Lattime, Peter A. McCue, Sarah Kim, Paul B. Chapman, Michael J. Mastrangelo

Institution: Thomas Jefferson University

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, U.S. Public Health Service, National Cancer Institute

Awards: PHASE IB TRIAL OF IMMUNOTHERAPY/IL-2-CYTOTOXIC CELLS, G3896985684, G6907493810

OpenAlex ID: W1968858357

FWCI: 0.146

Cites: 11

Cited by: 12

Related to: 10